Article
Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R).
Clinical research in cardiology supplements - 1 Jun 2012
Schaefer Juergen R, Kurt Bilgen, Sattler Alexander, Klaus Günter, Soufi Muhidien
Abstract excerpt
OBJECTIVE: Familial hypercholesterolemia (FH) is an autosomal dominant inherited disorder caused by mutations in the low density lipoprotein receptor (LDLR) gene. FH is characterized by elevated plasma LDL cholesterol, premature atherosclerosis, and a high risk of premature myocardial infarction. In general, mutations within LDLR gene can cause five different classes of defects, namely: class I defect: no LDLR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
